News

Vir Biotechnology, Inc. announced the publication of new research characterizing a novel site of vulnerability on the SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) spike protein – specifically the N-terminal domain (NTD). The study findings were made available online on...

Cytiva launches the “Exosome Challenge,” an industry challenge to overcome hurdles in exosome production and manufacturing. The challenge will focus on the standard workflow, in three focus areas: Cell engineering: Developing innovative technologies to engineer cell lines that can produce...

Avid Bioservices, Inc. and Humanigen, Inc. announced that they have entered into a manufacturing services agreement to expand production capacity for lenzilumab™, Humanigen’s therapeutic candidate in development for COVID-19. Lenzilumab is an anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal...

Novartis announced that asciminib, a novel investigational treatment specifically targeting the ABL myristoyl pocket (STAMP), has been granted Breakthrough Therapy designation (BTD) by the US FDA for the treatment of adult patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+...

Thermo Fisher Scientific, the world leader in serving science, today launched its CE-IVD-Marked, Applied Biosystems TaqPath COVID–19 HT Kit that is compatible with the Amplitude platform. The high-throughput solution enables clinical and public health laboratories to efficiently test up...

Union health minister Harsh Vardhan has said that the country is developing seven more Covid-19 vaccines to make them available to every citizen of India. “We are currently administering the Covishield and Covaxin vaccines to healthcare and frontline workers. The...

China’s national regulator has approved Sinovac Biotech’s COVID-19 vaccine for use by the general public. This is the second vaccine approved by China’s National Medical Products Administration (NMPA). Both of the vaccines, along with another experimental vaccine from Sinopharm, have...